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Abstract
Background: Computer Assisted Surgery (CAS) has proven to improve the accuracy in several orthopedic
procedures. Therefore we used this technique to evaluate femoral component positioning in Hip Resurfacing
Arthroplasty (HRA). The aim of this study was to evaluate imageless CAS compared to manually implanted femoral
components and subsequently evaluates Patient Related Outcome Measures (PROMs). We hypothesized that the
use of CAS optimizes the position of the femoral component and improves PROMs.
Methods: This is a multicenter, single-blinded, randomized, controlled trial of two groups. In the CAS group
guiding of the femoral component was done with imageless navigation. In the Conventional (control) group the
femoral component was placed manually according to the preplanned position. The primary outcome measure
consists of a maximum of 3 degrees difference between the postoperative Stem Shaft Angle (SSA) and preplanned
SSA. Secondary outcome measures consist of the Hip disability and Osteoarthritis Outcome Scale (HOOS), the Harris
Hip Score (HHS) and Visual Analogue Scale (VAS) pain score.
Results: A total of 122 patients were randomized, 61 in the CAS group and 61 in the conventional group. There
was no significant differences in accuracy of femoral implant position. The mean difference between the
postoperative- and preplanned SSA was − 2.26 and − 1.75 degrees (more varus) respectively in the CAS and
Conventional group. After surgery both groups show significant improvement in all PROMs compared to the
baseline measurements, with no significant differences between the groups.
Conclusion: Our cohort indicates no benefit for the use of CAS in accuracy of placement of the femoral
component in HRA compared to manual implantation. There are no clinical differences in PROMs after 1 year follow
up. This study showed no added value and no justification for the use of CAS in femoral component positioning in
HRA.
Trial registration: This trial is registered at ClinicalTrails.gov (https://clinicaltrials.gov/) on the 25th of October 2006:
NCT00391937.
Level of incidence: Level IIb, multicenter randomized controlled trial.
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Background
Hip Resurfacing Arthroplasty (HRA) is still considered a
viable treatment option for young and active patients
with end-stage osteoarthritis of the hip. Initially, this
Metal-on-Metal (MoM) articulation showed promising
short-term results, with high early return to work rates
and high rates of participation in sports activities [1–3].
However, there have been a high number of early fail-
ures and a high revision rates [4–8]. This led to a recall
of several MoM hip bearings, a more frequent follow-up
of patients, and finally to a reduced use of HRA’s world-
wide. Nevertheless, several HRA’s, are still used and
reasonable survival rates have been reported. For some
implants and patient categories equal to Total Hip
Arthroplasty [9, 10].
The implantation of a HRA is a challenging procedure,
due to reduced visibility and little exposure of the hip
joint. A non-optimal placement of the femoral compo-
nent is related to early femoral neck fractures, loosening,
notching and higher risk of impingement with increased
wear [11–14]. Therefore, an optimization of positioning
of the femoral component in HRA could increase the
survival of this bearing and possibly improve Patient
Reported Outcomes (PROs).
Computer-Assisted-Surgery (CAS) was introduced to
improve the accuracy of component positioning and
survival of orthopedic implants. CAS has shown to result
in an optimization of implant positioning in total hip
arthroplasty [15–17] and an accurate component posi-
tioning in HRA’s [18–22]. However, there is no clear
evidence that CAS improves the femoral positioning in
HRA compared to manual placement.
Therefore, in this multi-center, patient-blinded, random-
ized controlled trail (RCT) we compared femoral compo-
nent positioning between CAS and manual placement. The
primary outcome measure was ability to achieve a postop-
erative Stem-Shaft Angle (SSA) within 3 degrees of the pre-
planned SSA. Secondly, we compared different PROMs
between the two groups. We hypothesized that CAS results
in a more accurate femoral component position and im-
proves PROMs within one-year follow-up.
Methods
Study design
All consecutive patients who received an Articular Surface
Replacement (ASR) prosthesis (DePuy International Ltd.,
Leeds, UK) were recruited between October 2006 and
January 2010. Patients under the age of 60 (men) and 55
(women) years with nocturnal pain and/or limited walking
distance, osteoarthritis (Kellgren Lawrence grade ≥ 2) of
the hip, resistant to conservative treatment and eligible for
a resurfacing hip prosthesis were asked to participate.
Exclusion criteria consisted of a contralateral total hip
prosthesis, body mass index > 30 kg/m2, request to correct
an existing leg length discrepancy, not willing to partici-
pate in follow-up, proven metal allergy, evident osteopor-
osis, pathology of the acetabulum (evident acetabular
dysplasia: CE angle of < 15 degrees, hip dysplasia, slipped
capital femoral epiphysis and Legg-Calve-Perthes disease),
previous hip surgery, vascular deficiency of the lower ex-
tremity, renal deficiency, active local or systemic infection,
use of steroids and/or immunosuppression, femoral ana-
tomic anomaly, femoral head neck ratio < 1, and extreme
varus position (neck-shaft angle < 110 degrees). Conserva-
tive treated acetabular fractures were not excluded.
Patients were randomized using concealed allocation via
a specifically designed website. Stratification took place
per orthopaedic surgeon. All patients were blinded for the
allocation, whereas the surgeon could not be blinded for
the procedure. A standardized anteroposterior (AP) pelvic
X-ray was used for calculation of the Centrum-Collum-
Diaphysis (CCD)-angle and for preplanning of the femoral
component. The software used for the preplanning was
OrthoView (OrthoView, Meridian Technique Limited,
Southampton, United Kingdom). Power analysis calcu-
lated a minimal of 117 patients per group in order to show
a mean absolute difference of minimally 3 degrees be-
tween the postoperative SSA and preplanned SSA (one-
side testing alpha = 0.05 and beta = 0.80). This sample size
calculation is based on the study of Beaule et al., were they
investigated the relation between the orientation of the
femoral component and outcome of an ASR prosthesis
[12]. With a follow-up period of three years, a 20%
dropout was calculated and an inclusion of a total of 280
patients (140 each group) needed.
Surgical planning and technique
Eleven experienced orthopedic hip replacement surgeons
were trained to use the CAS-system. They attended an
obligatory hands-on instructional cadaver course and a
saw bone training. All operations were performed using
a standard posterolateral approach. In the CAS group,
surgical guiding of the femoral component was done
with BrainLab Ci™ ASR System 1.0 (BrainLAB AG, Feld-
kirchen, Germany). There was no additional dissection
necessary for CAS compared to the standard hip resur-
facing surgery. Both groups received identical antibiotic
prophylaxis with Cephalosporin (1000 mg) direct pre-
operatively and 24-h postoperatively. Thrombosis
prophylaxis with Nadroparine was given until 6 weeks
postoperatively. A standardized pain medication proto-
col was used postoperatively. Patients were rehabilitated
under the guidance of the physiotherapist with immedi-
ate unrestricted weight bearing.
Radiological evaluation
To calculate the CCD-angle, the preoperative standard-
ized AP-pelvic X-ray was analyzed in a blinded manner
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by two of the authors (MCK, EvE) using GeoGebra
(International GeoGebra Institute and GeoGebra GmbH,
freeware). Figure 1a demonstrates the use of GeoGebra
where multiple marks are placed on the collum and the
shaft to calculate the CCD angle. The SSA, defined as
the angle between the stem of the femoral HR compo-
nent and the axis of the femoral diaphysis in the AP
projection, was measured on the preplanned AP-pelvic
X-ray and direct postoperative AP-pelvic X-ray (Fig. 1b).
Clinical evaluation
The Hip disability and Osteoarthritis Outcome Scale
(HOOS), the Visual-Analogue-Scale (VAS) pain score
and the Harris-Hip-Score (HHS) were used to evaluate
relevant patient-centered outcomes.
The HOOS is subcategorized in five domains; pain,
symptoms, function in daily life, sports and hip related
quality of life. Scores on the HOOS range from 0 to 100,
where 0 indicates the worst possible outcome and 100
the best possible [23]. The VAS pain is a validated tool
to evaluate pain perception of a patient, and scores range
from 0 to 10, with 0 indicating no pain an 10 being the
worst pain experienced [24]. At each outpatient visit the
HHS was completed by the orthopedic surgeon and used
to score the hip function [25]. The survey has 10 ques-
tions and score a range from 0 to 100 with higher scores
represent less dysfunction and better outcome.
Data collection
Surgical blood loss and surgery duration were logged by
the anesthesiologist and written on the surgery
evaluation form. Each adverse event was classified as
‘surgical’ when it occurred in the operation room, as
‘early’ when it occurred within three months after sur-
gery, and as ‘late’ when it occurred more than three
months postoperatively. At the end of the trial, all hos-
pital records of the participating patients were retrieved
and checked to verify the adverse events and their
extensiveness.
Baseline questionnaires were administered before
surgery, and subsequently at 6 weeks, 3 and 12months
postoperative. At each outpatient visit, the HHS was
completed by the orthopedic surgeon. The other ques-
tionnaires were patient-reported and were sent out elec-
tronically (web-based or via email) or sent on paper by
post.
Statistical analysis
Descriptive statistics including means, standard devia-
tions, frequencies and percentages were used to describe
the patient characteristics. For all X-ray measurements
the intra-observer and inter-observer reliability were
evaluated using the intra-class correlation coefficient
(ICC). We used a two-way mixed model with absolute
agreement and a confidence interval of 95%. The ICC
values range from 0 to 1, in which 1 indicates perfect re-
liability and an ICC greater than 0.75 considered accept-
able [26].
Intention-to-treat analyses were used for all variables.
However, due to some protocol violations, all data were
also analyzed per protocol. The independent t-test was
used to assess differences between groups for continuous
Fig. 1 Examples of the use of GeoGebra (International GeoGebra Institute and GeoGebra GmbH, freeware) to calculate the Center-Collum-
Diaphysis (a) and the postoperative Stem-Shaft-Angle (b)
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data, while the Chi-square test was used to assess differ-
ences in categorical data. To assess differences in con-
tinuous data over time within the same treatment group,
a paired t-test was used. For the implant survival ana-
lysis, a Kaplan-Meier was used to compare treatment
groups. Events were defined as revisions of the femoral
and/or acetabular component for any reason, and pa-
tients without an event were censored at 3 year postop-
erative. All analyses were performed using SPSS 20(IBM
Corporation, Armonk, NY). All tests were two-sided and
a p-value < 0.05 was considered significant.
Results
During the trial period, a total of 125 patients (133 hips)
were included, 67 hips were randomized to the conven-
tional group and 66 hips to the CAS group. The study
flowchart is depicted in Fig. 2 and patient characteristics
in Table 1. A total of 11 randomized patients were ex-
cluded due to primary missing data and loss of follow
up, five patients in the conventional group and six pa-
tients in the CAS group. These patients showed no dif-
ference in baseline characteristics. In general, patients in
both groups were similar, except for BMI, which was
significantly higher in the CAS group (26.9 versus 25.5,
p = 0.003), which can be explained by a higher body
weight (Table 1). Unfortunately, due to an international
recall of the ASR prosthesis after publications of high
complication and failure rates the study was prematurely
ended. This resulted in a lower number of inclusions
needed and incompleteness of data gathered by the par-
ticipated orthopedic surgeons.
Surgical details
Table 2 shows the details on the surgical procedure for
each group. The mean operation time in the CAS group
was significantly(p < 0.001) longer, i.e. 19 min. Three
minor ‘early’ adverse events were reported, all in the
conventional group. One patient had minor cardiac is-
chemia, the second patient complained of a painful
lower leg and swelling, but thrombosis was excluded.
The third patient had a superficial skin infection and re-
quired oral antibiotics. All resolved without further
problems.
Protocol violations occurred thirteen times. Ten of the
CAS randomized patients were operated without CAS
due to no CAS system availability during surgery. Two
Fig. 2 Study flowchart
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patients in the CAS group were excluded because safe
femoral component placement was considered not pos-
sible and a total hip prosthesis was implanted. One con-
ventional randomized patient was operated with CAS.
Radiographic evaluation
The intra-observer reliability for the two readers was ex-
cellent: 0.98, 95% CI 0.94–0.996 for reader 1, and 0.96,
95% CI 0.91–0.99 for reader 2. The ICC for the inter-
observer reliability was 0.95, 95% CI 0.89–0.99. The
mean native CCD-angle was 129 degrees in both groups,
with no significant difference between the groups. We
did find a significant difference (P = 0.033) in the pre-
planned SSA within the intention to treat analysis. This
is a baseline difference and we do not have a clear ex-
planation for this and believe this is not of any clinical
relevance for the outcome of this study. The mean post-
operative SSA minus the preplanned SSA showed no
significant difference between the two groups (p =
0.636). A slightly more varus position was found in both
groups with − 2.26 and − 1.75 degrees deviation respect-
ively in the CAS and conventional group. Analysis of pa-
tients with more than 3 degrees, 7 degrees or 10 degrees
deviation also showed no significant difference. Table 3
shows all measured data calculated as intention to treat,
as well as calculations per protocol.
Clinical evaluation
Compliance rates for the different questionnaires ranged
between 87 and 100% at baseline, 70–90% after 6 weeks,
70–90% after 3 months and 67–90% after 12 months of
follow-up. Reasons for missing data are the international
recall of the prosthesis and shutdown of the study web-
site. Table 4 describes all results of the questionnaires
during the one year follow-up visits, separately for the
two groups.
The baseline mean VAS score in both groups de-
creased significantly(P = 0.000) after 6 weeks of surgery.
Between both groups no significant difference at any
time point was observed. The HOOS questionnaire at
baseline showed no differences between the CAS and
conventional group in pain, hip-related quality of life
and other symptoms. The conventional group showed
significant higher scores in the subscales activities of
daily living(P = 0.028) and sport(P = 0.021) at baseline.
After 6 weeks, 3 months and one year follow up, no
significant differences between the two groups were
observed.
The mean HHS was significantly increased in both
groups after six weeks(P = 0.000), three months(P =
0.000) and 1 year(P = 0.026) of surgery.
Survival analysis
During a three-year follow-up period, 11 revisions were
performed. An overall survival of 91% in three years was
calculated in the entire group. Table 5 shows the revi-
sion characteristic between the two groups. All late
events in our clinics were managed with a conventional
total hip arthroplasty. With per protocol analysis we
found more revisions in the conventional group versus
the CAS group (8 versus 3) in the three-year follow-up
period, this difference was not significant. Figure 3
shows the Kaplan-Meier survival curve between the two
groups.
Table 1 Baseline patient characteristics for the CAS and Conventional group
CAS (n = 61) Conventional (n = 61) P-value Excluded hips (n = 11)
Age (years) (SD: range) 50 (6.3: 22 to 60) 50 (6.4: 29 to 60) 0.887 45.64 (6.9: 37–59)
Weight (kg) (SD: range) 85.6 (11.3: 62–107) 79.7 (12.27: 53–110) 0.006* 77.9 (11.5: 55–95)
Length (cm) (SD: range) 178.3 (8.9: 161–196) 176.2 (9.2: 157–196) 0.210 175.2 (10.5: 164–197)
BMI (kg/m2) (SD: range) 26.9 (2.6: 20.3 to 30.1) 25.5 (2.4: 20.4–29.4) 0.003* 25.3 (2.9:19.0–29.8)
Gender (Men: Women) 39: 22 42: 19 0.702 6:5
Side (L: R) 25:36 29:32 0.585 7:3
CAS Computer-Assisted-Surgery, BMI Body Mass Index
Age, Weight, Length and BMI are presented as means. Gender and Side are given as a ratio
Table 2 Surgery details of the CAS and Conventional groups
CAS (n = 61) Conventional
(n = 61)
P-value
Surgery time (min)
(SD: range)
116 (30: 65–240) 97 (24: 60–180) 0.000*
Blood loss (mL)
(SD: range)
645 (276: 200–1500) 573 (282: 150–1500) 0.171
Component size
(mm) (SD: range)
49 (3: 43–57) 49 (3: 41–57) 0.635
CAS protocol
deviations
12 1
- Conventional
/CAS
10 1
- Total Hip
Prosthesis
2 0
CAS Computer-Assisted-Surgery
Surgery time, Blood loss and Component size are given as means. CAS
protocol deviations are given as counts
* Significant difference between CAS and Conventional group, P < 0.000
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Discussion
In this multi-center, patient-blinded, randomized con-
trolled study we compared imageless CAS versus manual
placement of the femoral component in HRA. The pri-
mary endpoint of this study was an accurate placement
of the femoral component within 3 degrees difference
between the postoperative SSA and preplanned SSA. We
did not find a difference in accuracy between the CAS
and conventional group.
An accurate positioning of the femoral component in
HRAs remains a critical step during surgery. A non-
optimal placement of the femoral component is related
to early failure. An excessive valgus position results is an
increased risk of femoral notching and weakening of the
bone with possible avascular necrosis, while a varus pos-
ition leads to increased femoral neck fractures and
aseptic loosening [11, 13, 14, 27, 28]. Increased metal
ion levels, adverse reaction to metal debris (ARMD) and
pseudotumor formation also seem related to a subopti-
mal position of components, which may result in in-
creased revision rates [5, 29, 30]. The importance of
CAS in component placement in HRA is already shown
in preclinical and clinical studies [18, 31–36]. However,
most of these clinical studies retrospectively evaluated
case series. In this RCT the CCD-angle, preplanned SSA
and postoperative SSA were all determined with high
intra- and interobserver reproducibility, showing the ac-
curacy of our measurements. The CCD angle in our
study was similar for the two treatment groups. We only
found a small but significant difference in the pre-
planned SSA (P = 0.003) between the two groups; 138
degrees in the CAS group compared to 137 degrees in
Table 3 Radiographic evaluation of the angles
Radiographic evaluation angles (shown as intention to
treat)
Radiographic evaluation angles (shown per protocol)
CAS (n = 61) Conventional
(n = 61)
P
Value
CAS (n = 50) Conventional
(n = 70)
P Value
CCD-Angle, degrees
(SD: range)
129,5 (6.1: 117–143) 128,6 (6.5: 115–149) 0.443 129,2 (6.1: 117–143) 128,9 (6.5: 115–149) 0.780
Preplanned SSA, degrees
(SD: range)
138,3 (3.8: 128–148) 136,6 (4,8: 127–152) 0.033* 138,0 (3.8: 128–148) 137,1 (4,7: 127–152) 0.281
Post-operative SSA, degrees
(SD: range)
136,0 (5.7: 124–150) 134,9 (6,7: 119–153) 0.311 136,3 (5.6: 124–150) 134,8 (6,6: 119–153) 0.196
Difference postoperative
SSA minus preplanned SSA
- Mean, degrees
(SD: range)
−2.26 (5.8: −15.25 –
12.11)
−1.75 (5.9: − 13.14 –
16.21)
0.636 − 1.7 (5.9: − 15.25 –
12.11)
− 2.2 (5.8: − 13.14 –
16.21)
0.592
- Absolute, degrees
(SD: range)
5.14 (3.5: 0.07–15.25) 4.94 (3.5: 0.04–16.21) 0.768 5.0 (3.5) 5.0 (3.5) 0.932
- > 3 degrees, n (%) 44 (72%) 40 (66%) 0.558 35 (70%) 44 (61%) 0.692
- > 7 degrees, n (%) 18 (29%) 19 (31%) 0.884 12 (24%) 20 (28%) 0.534
- > 10 degrees, n (%) 6 (10%) 4 (7%) 0.517 05 (10%) 10 (14%) 0.586
CAS = Computer-Assisted-Surgery, CCD = Centrum-Collum-Diaphysis, SSA = Stem-Shaft-Angle.* significant difference
Table 4 Patient Reported Outcomes with one year follow up. Calculated per protocol
Baseline Six weeks Three months One year P-value
(LMM)
CAS Conventional CAS Conventional CAS Conventional CAS Conventional
VAS 5.7 (1.9) 5.4 (2.0) 1.3 (2.0) 1.3 (1.8) 0.8 (1.3) 0.8 (1.3) 0.4 (1.0) 0.5 (1.2) 0.688
HOOS Pain 38.4 (13.0) 40.5 (15.4) 81.1 (15.5) 79.2 (13.3) 87.0 (15.6) 86.5 (14.7) 91.1 (11.2) 88.0 (16.7) 0.432
Other symptoms 35.0 (14.4) 35.7 (14.2) 67.2 (16.7) 69.0 (15.5) 72.5 (16.1) 72.2 (16.1) 74.5 (18.0) 75.9 (19.6) 0.914
Activities of daily
living
38.2 (14.9) * 42.7 (16.4) * 72.8 (17.3) 71.2 (13.5) 83.2 (17.6) 82.2 (15.2) 89.6 (11.7) 87.3 (16.3) 0.333
Sport 16.6 (14.0)
**
22.8 (18.3) ** 53.6 (29.2) 46.2 (25.6) 69.9 (26.0) 65.8 (25.6) 73.8 (24.2) 76.6 (23.2) 0.444
Hip-related QoL 21.7 (12.3) 24.5 (11.7) 51.9 (16.1) 48.4 (16.7) 66.5 (20.2) 59.6 (17.9) 71.9 (14.6) 69.0 (20.9) 0.309
HHS Total 57.1 (10.6) 60.6 (10.6) 79.1 (16.6) 80.2 (11.5) 91.0 (12.8) 93.7 (8.7) 96.3 (7.1) 97.8 (4.0) 0.537
CAS Computer-Assisted-Surgery, LMM linear mixed-model, VAS visual analogue scale. HOOS=Hip disability and Osteoarthritis Outcome Scale (HOOS). HHS=Harris
Hip Score. All data are presented as means (SD). * significant difference (p = 0.028). ** significant difference (p = 0.021)
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Table 5 Revision characteristics for the CAS and Conventional group
Age/Gender Size
component
(mm)
Revision indication Time to revision
(months)
Component
revised
Anatomy
(degrees)
Angle planned
(degrees)
Angle post
(degrees)
CAS randomized 46/Female 46 Collum fracture 3 Femur Normal
(128)
133 124
56/Male 49 Collum fracture 25 Femur Coxa Valga
(136)
142 135
51/Male 53 ARMD, high
cobalt/chromium
29 Femur +
Acetabulum
Normal
(130)
136 142
54/Female
(no CAS)
47 Aseptic loosening 30 Femur +
Acetabulum
Normal
(129)
134 131
53/Female
(no CAS)
46 Collum fracture 1,5 Femur Coxa Valga
(141)
143 –
Conventional
randomized
52/Male 49 Pain 25 Femur Normal
(122)
137 133
55/Female 45 Aseptic loosening 8 Femur +
acetabulum
Normal
(127)
133 141
53/Female 43 Aseptic loosening 21 Femur +
Acetabulum
Normal
(126)
136 140
59/Male 51 Pain, high cobalt/
chromium
23 Femur +
Acetabulu
Normal
(127)
138 136
54/Female 41 ALTR 22 Femur +
Acetabulum
Coxa Valga
(135)
132 149
48/Male 51 Aseptic loosening 0.5 Acetabulum Normal
(134)
138 134
CAS, Computer-Assisted-Surgery, ARMD Adverse Reaction to Metal Debris
Fig. 3 The 3 year survival Kaplan-Meier curve between the CAS and Conventional group. No significant difference (p = 0.304) in survival
was found
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the conventional group. However, we consider this dif-
ference not of clinical significance. We did not observe
any difference in the mean postoperative SSA between
the two treatment groups, nor in the number of hips
with a postoperative difference in SSA of ≥3, ≥7 or ≥ 10
degrees from the preplanned SSA. These results show
that CAS did not result in an increased accuracy in
placement of the femoral component. In contrast to our
results, Stiehler et al., did show a significant improve-
ment in placement of the femoral component with the
use of CAS. Fewer femoral components were positioned
in ≥5 degrees absolute deviation compared to preplan-
ning in the CAS group [19]. In another, retrospective
study, they showed a more accurate placement of the
femoral component and less deviations from the planned
SSA was accomplished with the use of CAS [37].
The impact of CAS on several aspects of patients’
functioning (HHS, HOOS and VAS) was evaluated dur-
ing a one-year follow-up period. Although the patients
differed in their level of activities of daily living and
sport at baseline, these differences were not clinically
relevant. We did observe an overall improvement of pa-
tients’ functioning over time, but this was similar for the
two treatment groups. All results are consistent with
previous studies [9, 19, 37].
Our study has several limitations. Unfortunately due
to recall of the ASR system, the study was prematurely
terminated, resulting in a lower number of patients than
needed, possibly hampering our statistical analysis. Se-
lective protocol deviations due to incidentally unavail-
ability of the CAS system in certain surgeries possibly
influenced our study outcome. In this case, per protocol
analysis would provide a better estimate of the effects of
this method. Lastly, our longitudinal analysis of PROs
was hampered by missing data. As missing data occurred
due to termination of the study, selective bias will be
limited, as patients who completed the data are repre-
sentative of the study population.
Conclusions
Despite the limitations and recall of the ASR prosthesis
we feel obligated to present our results. As orthopedic
surgeons we have to strive to perform better and always
search for optimization of a procedure. In our study, we
show no added value for the use of imageless CAS in
placement of the femoral component. In addition, CAS
also did not improve any of the Patient-Centered Out-
comes after one year follow up. Therefore we do not ex-
pect that CAS will result in long-term event-free
survival, but this remains to be determined in long-term
follow up.
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